Carl Adams

Comptroller/Controller/Auditor at TELEDYNE TECHNOLOGIES INCORPORATED

54 year

Consumer Services

Health Technology

Electronic Technology

Profile

Carl Adams is currently the Chief Audit Executive & Vice President at Teledyne Technologies, Inc. He previously worked as the Chief Financial Officer & Vice President at NeuroSigma, Inc. in 2014.
He completed his undergraduate degree at California State University-Northridge.

Carl Adams active positions

Companies	Position	Start
TELEDYNE TECHNOLOGIES INCORPORATED	Comptroller/Controller/Auditor	01/12/2023

All active positions of Carl Adams

Former positions of Carl Adams

Companies	Position	End
NeuroSigma, Inc. NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA.	Director of Finance/CFO	-

See the detail of Carl Adams's experience

Training of Carl Adams

California State University-Northridge

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Carl Adams's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
TELEDYNE TECHNOLOGIES INCORPORATED	Electronic Technology

Private companies	1
NeuroSigma, Inc. NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA.	Health Technology